review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Martin A Valdivia-Arenas | |
Rami N Khayat | |||
Michael Powers | |||
P2860 | cites work | Sleep in the intensive care unit | Q79177333 |
The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment | Q79385585 | ||
[Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure] | Q80010630 | ||
Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients | Q28267419 | ||
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis | Q28305437 | ||
The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study | Q29615583 | ||
Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model | Q30500690 | ||
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology | Q34389554 | ||
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study | Q34508280 | ||
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). | Q34557005 | ||
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population | Q34568746 | ||
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation | Q34574714 | ||
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q34595917 | ||
Sleep apnea and hypertension. A population-based study | Q34729301 | ||
Sleep apnea and heart failure: Part I: obstructive sleep apnea | Q35095882 | ||
Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome | Q48848087 | ||
Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. | Q48863524 | ||
Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea | Q48868124 | ||
Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. | Q50921439 | ||
Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. | Q50980294 | ||
Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. | Q51697002 | ||
Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure. | Q51705285 | ||
Neural mechanism of the pressor response to obstructive and nonobstructive apnea. | Q53794129 | ||
Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema | Q60147257 | ||
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD) | Q68430599 | ||
Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group | Q70733060 | ||
Influence of treatment on muscle sympathetic nerve activity in sleep apnea | Q71046220 | ||
Negative pressure-induced deformation of the upper airway causes central apnea in awake and sleeping dogs | Q71314467 | ||
Reversal of central sleep apnea with oxygen | Q71975055 | ||
Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure | Q72611413 | ||
Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction | Q73087526 | ||
Population-based study of sleep-disordered breathing as a risk factor for hypertension | Q73570777 | ||
Hypoxia augments apnea-induced peripheral vasoconstriction in humans | Q73613540 | ||
The economic burden of heart failure | Q73646183 | ||
Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure | Q73665629 | ||
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study | Q73782355 | ||
Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure | Q48480528 | ||
Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome | Q48481426 | ||
Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea | Q48484744 | ||
Validation and clinical utility of a simple in-home testing tool for sleep-disordered breathing and arrhythmias in heart failure: results of the Sleep Events, Arrhythmias, and Respiratory Analysis in Congestive Heart Failure (SEARCH) study | Q48488353 | ||
Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects | Q48489723 | ||
Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea | Q48490151 | ||
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up | Q48503331 | ||
Increased propensity for apnea in response to acute elevations in left atrial pressure during sleep in the dog. | Q48504256 | ||
Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure | Q48506489 | ||
Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea | Q48525048 | ||
Effectiveness of short-term treatment with nocturnal oxygen therapy for central sleep apnea in patients with congestive heart failure. | Q48537296 | ||
Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats | Q48547568 | ||
Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure | Q48548128 | ||
Association of atrial fibrillation and obstructive sleep apnea | Q48587853 | ||
Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 | ||
Cardiorespiratory Effects of Added Dead Space in Patients With Heart Failure and Central Sleep Apnea | Q48628760 | ||
Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea | Q48640268 | ||
Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome | Q48643754 | ||
Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea | Q48661778 | ||
Apnea-hypopnea threshold for CO2 in patients with congestive heart failure | Q48663138 | ||
Is Cheyne-Stokes Respiration Detrimental in Patients with Heart Failure? | Q48669078 | ||
Obstructive apnea during sleep is associated with peripheral vasoconstriction | Q48673756 | ||
Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay | Q48704758 | ||
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 | ||
Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea | Q48709586 | ||
Respiratory disturbance index: an independent predictor of mortality in coronary artery disease | Q48717540 | ||
Acute and chronic effects of airway obstruction on canine left ventricular performance | Q48737323 | ||
Pulmonary edema develops after recurrent obstructive apneas | Q48738997 | ||
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure | Q48741847 | ||
High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months | Q48749160 | ||
Reduced cardiac sympathetic autonomic tone after long-term nasal continuous positive airway pressure in obstructive sleep apnoea syndrome | Q48766821 | ||
Influence of pulmonary capillary wedge pressure on central apnea in heart failure | Q48768829 | ||
Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure | Q48783783 | ||
Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia | Q48809642 | ||
Pharyngeal narrowing/occlusion during central sleep apnea | Q48821308 | ||
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. | Q35537962 | ||
Risk factors for obstructive sleep apnea in adults | Q35758496 | ||
Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. | Q35771464 | ||
Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis | Q36062632 | ||
The influence of aging on pharyngeal collapsibility during sleep. | Q36516012 | ||
Endothelial function and dysfunction: testing and clinical relevance | Q36758044 | ||
Pharyngeal motor control and the pathogenesis of obstructive sleep apnea | Q36942305 | ||
Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea | Q39645233 | ||
Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms | Q40511330 | ||
Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. | Q40601306 | ||
Influence of obstructive sleep apnea on mortality in patients with heart failure | Q43433552 | ||
Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure | Q43444051 | ||
Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up | Q43444057 | ||
Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure | Q43607694 | ||
Routine polysomnography is not indicated in congestive heart failure. Con. | Q43979775 | ||
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease | Q44047539 | ||
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations | Q44554087 | ||
Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure | Q44641932 | ||
Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnoea | Q44735636 | ||
Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. | Q44875227 | ||
Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure | Q45167544 | ||
Cardiac autonomic control in obstructive sleep apnea: effects of long-term CPAP therapy. | Q45991382 | ||
Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. | Q46455337 | ||
Influence of obstructive sleep apnea on heart rate turbulence | Q46535786 | ||
Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy | Q46667008 | ||
Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure | Q46763829 | ||
Continuous positive airway pressure for central sleep apnea and heart failure | Q46799634 | ||
Antioxidant vitamin C improves endothelial function in obstructive sleep apnea | Q46913805 | ||
Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea | Q47341818 | ||
A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome | Q47342317 | ||
Bilevel positive airway pressure worsens central apneas during sleep | Q47706845 | ||
Cerebrovascular response to carbon dioxide in patients with congestive heart failure | Q47794875 | ||
Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction? | Q47833395 | ||
Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema | Q47879922 | ||
Crossing the apnoeic threshold: causes and consequences | Q47887447 | ||
Prevalence of sleep disordered breathing in a heart failure program | Q47915674 | ||
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation | Q47918768 | ||
Increased long-term mortality in heart failure due to sleep apnoea is not yet proven | Q47973711 | ||
Role of sensory input from the lungs in control of muscle sympathetic nerve activity during and after apnea in humans | Q47995315 | ||
Clinical efficacy and cost-benefit analysis of nocturnal home oxygen therapy in patients with central sleep apnea caused by chronic heart failure | Q48453152 | ||
Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing | Q48453630 | ||
Sleep apnoea screening in heart failure? Not until benefit is proven! | Q48467339 | ||
Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea | Q48469918 | ||
Sleep apnoea in heart failure | Q48474659 | ||
Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction | Q48478550 | ||
The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea | Q48479132 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart failure | Q181754 |
breathing | Q9530 | ||
P304 | page(s) | 183-193 | |
P577 | publication date | 2008-08-29 | |
P1433 | published in | Heart Failure Reviews | Q2167497 |
P1476 | title | Sleep-disordered breathing in patients with decompensated heart failure | |
P478 | volume | 14 |
Search more.